Effects of antihypertensive agents on coronary artery disease risk factors.
The adverse effects of certain antihypertensive medications, most notably diuretics and beta blockers, on serum lipids, glucose, and potassium may explain why control of hypertension has not been accompanied by declines in coronary artery disease. Evidence indicates that angiotensin-converting enzyme (ACE) inhibitors, including quinapril, the newest member of this class of drugs, have no deleterious effects on these coronary risk factors. In addition to differences in chemical structure, the unique activity of quinapril at the local tissue level might to some degree explain its comparatively favorable clinical profile. Consequently, ACE inhibiting agents may be better choices for the management of patients with mild-to-moderately elevated blood pressure. However, controlled clinical trials with these drugs are needed to determine their impact on events related to coronary artery disease.
Schoenberger
J A
JA
Rush-Presbyterian-St. Luke's Medical Center, Chicago, Illinois 60612.
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000009:adverse effects*; D001786:Blood Glucose / Q000187:drug effects*; D003327:Coronary Disease / Q000097:blood* / Q000139:chemically induced; D006801:Humans; D008074:Lipoproteins / Q000187:drug effects*; D011188:Potassium / Q000097:blood*; D012307:Risk Factors
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001786:Blood Glucose; D008074:Lipoproteins; D011188:Potassium